Skip to main content
. Author manuscript; available in PMC: 2022 Feb 23.
Published in final edited form as: Biologicals. 2018 Nov 18;57:9–20. doi: 10.1016/j.biologicals.2018.11.001

Table 5.

Antigen lot comparison.

Antigen Vendor Lot # Normalized Mean Percent Difference

Act List MM0110 0.87113 −12.89%
List MM0109 0.90625 −9.38%
EH MM0106 0.96349 −3.65%
EH MM0105 0.98242 −1.76%
List BP MM0103 0.99233 −0.77%
List BP MM0104 1.06208 6.21%
Sigma MM0112 1.10789 10.79%
Sigma MM0111 1.11439 11.44%

Fha List MM0083 0.97715 −2.29%
List MM0084 1.00211 0.21%
SP MM0081 0.98069 −1.93%
SP MM0082 1.04005 4.00%

Fim2/3 List MM0101 0.96868 −3.13%
List MM0102 0.98569 −1.43%
SP MM0099 1.00195 0.19%
SP MM0100 1.04368 4.37%

Prn List MM0095 1.03112 3.11%
List MM0096 1.05225 5.22%
SP MM0093 0.92874 −7.13%
SP MM0094 0.98788 −1.21%

Pt List MM0089 0.98973 −0.77%
List MM0090 0.99739 0.00%
SP MM0087 0.97409 −2.34%
SP MM0088 1.03879 4.15%

List = List Biologies Inc; EH = Erik Hewlett; Sigma = Sigma-Aldrich; SP = Sanofi Pasteur.

Act – Adenylate cyclase; Fha – filamentous hemagglutinin; Fim2/3 - Fimbria; Prn – Pertactin; Pt – Pertussis toxin antigens.

Percent difference: Percent difference was calculated as the percent change of the normalized mean from 1.0 with the accepted range between ± 20%.